Trials / Completed
CompletedNCT00411684
Safety and Efficacy of CDB-2914 for Emergency Contraception
A Prospective, Open-Label, Single Arm, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of CDB-2914 as Emergency Contraception When Taken Between 48 Hours and 120 Hours of Unprotected Sex
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,623 (actual)
- Sponsor
- HRA Pharma · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of CDB-2914 for preventing pregnancy when taken 3 to 5 days after unprotected sexual intercourse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CDB-2914 |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2008-04-08
- Completion
- 2009-06-05
- First posted
- 2006-12-14
- Last updated
- 2021-09-21
- Results posted
- 2021-05-03
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00411684. Inclusion in this directory is not an endorsement.